135 related articles for article (PubMed ID: 11495154)
21. Safety evaluation of Ad5CMV-p53 in vitro and in vivo.
Zhang WW; Alemany R; Wang J; Koch PE; Ordonez NG; Roth JA
Hum Gene Ther; 1995 Feb; 6(2):155-64. PubMed ID: 7734516
[TBL] [Abstract][Full Text] [Related]
22. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.
Liu TJ; Zhang WW; Taylor DL; Roth JA; Goepfert H; Clayman GL
Cancer Res; 1994 Jul; 54(14):3662-7. PubMed ID: 8033080
[TBL] [Abstract][Full Text] [Related]
23. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.
Weinrib L; Li JH; Donovan J; Huang D; Liu FF
Cancer Gene Ther; 2001 May; 8(5):352-60. PubMed ID: 11477455
[TBL] [Abstract][Full Text] [Related]
24. Growth suppression of esophageal squamous cell carcinoma induced by heavy carbon-ion beams combined with p53 gene transfer.
Oohira G; Yamada S; Ochiai T; Matsubara H; Okazumi S; Ando K; Tsujii H; Hiwasa T; Shimada H
Int J Oncol; 2004 Sep; 25(3):563-9. PubMed ID: 15289857
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis induced in human osteosarcoma cells is one of the mechanisms for the cytocidal effect of Ad5CMV-p53.
Wang J; Bucana CD; Roth JA; Zhang WW
Cancer Gene Ther; 1995 Mar; 2(1):9-17. PubMed ID: 7621257
[TBL] [Abstract][Full Text] [Related]
26. Adenoviral p53 gene therapy promotes heat-induced apoptosis in a nasopharyngeal carcinoma cell line.
Qi V; Weinrib L; Ma N; Li JH; Klamut H; Liu FF
Int J Hyperthermia; 2001; 17(1):38-47. PubMed ID: 11212879
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.
Miyake H; Yamanaka K; Muramaki M; Hara I; Gleave ME
Neoplasia; 2005 Feb; 7(2):171-9. PubMed ID: 15802022
[TBL] [Abstract][Full Text] [Related]
28. Modification of the Rb-binding domain of replication-competent adenoviral vector enhances cytotoxicity against human esophageal cancers via NF-kappaB activity.
Yamada K; Moriyama H; Yasuda H; Hara K; Maniwa Y; Hamada H; Yokono K; Nagata M
Hum Gene Ther; 2007 May; 18(5):389-400. PubMed ID: 17518613
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21).
Clayman GL; Liu TJ; Overholt SM; Mobley SR; Wang M; Janot F; Goepfert H
Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):489-93. PubMed ID: 8615965
[TBL] [Abstract][Full Text] [Related]
30. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.
Ishii H; Dumon KR; Vecchione A; Trapasso F; Mimori K; Alder H; Mori M; Sozzi G; Baffa R; Huebner K; Croce CM
Cancer Res; 2001 Feb; 61(4):1578-84. PubMed ID: 11245468
[TBL] [Abstract][Full Text] [Related]
31. p53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells.
Draus JM; Elliott MJ; Atienza C; Stilwell A; Wong SL; Dong Y; Yang H; McMasters KM
Exp Mol Med; 2001 Dec; 33(4):209-19. PubMed ID: 11795482
[TBL] [Abstract][Full Text] [Related]
32. In vitro adenoviral vector p53-mediated transduction and killing correlates with expression of coxsackie-adenovirus receptor and alpha(nu)beta5 integrin in SUDHL-1 cells derived from anaplastic large-cell lymphoma.
Turturro F; Seth P; Link CJ
Clin Cancer Res; 2000 Jan; 6(1):185-92. PubMed ID: 10656449
[TBL] [Abstract][Full Text] [Related]
33. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM
Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992
[TBL] [Abstract][Full Text] [Related]
34. [Apoptosis induced by adenovirus-mediated wild-type p53 expression in human pancreatic cancer cells].
Guo H; Liu T; Gao J
Zhonghua Bing Li Xue Za Zhi; 1998 Jun; 27(3):194-7. PubMed ID: 11244980
[TBL] [Abstract][Full Text] [Related]
35. Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells.
Ala-aho R; Grénman R; Seth P; Kähäri VM
Oncogene; 2002 Feb; 21(8):1187-95. PubMed ID: 11850838
[TBL] [Abstract][Full Text] [Related]
36. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M
Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734
[TBL] [Abstract][Full Text] [Related]
37. Adenoviral delivery of recombinant DNA into transgenic mice bearing hepatocellular carcinomas.
Bao JJ; Zhang WW; Kuo MT
Hum Gene Ther; 1996 Feb; 7(3):355-65. PubMed ID: 8835222
[TBL] [Abstract][Full Text] [Related]
38. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.
Clayman GL; el-Naggar AK; Roth JA; Zhang WW; Goepfert H; Taylor DL; Liu TJ
Cancer Res; 1995 Jan; 55(1):1-6. PubMed ID: 7805018
[TBL] [Abstract][Full Text] [Related]
39. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells.
Kagawa S; Fujiwara T; Hizuta A; Yasuda T; Zhang WW; Roth JA; Tanaka N
Oncogene; 1997 Oct; 15(16):1903-9. PubMed ID: 9365236
[TBL] [Abstract][Full Text] [Related]
40. Potentials and limitations of adenovirus-p53 gene therapy for brain tumors.
Hong YK; Joe YA; Yang YJ; Lee KS; Son BC; Jeun SS; Chung DS; Cho KK; Park CK; Kim MC; Kim HK; Yung WK; Kang JK
J Korean Med Sci; 2000 Jun; 15(3):315-22. PubMed ID: 10895975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
